Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

'First genetically edited porcine kidney xenotransplantation in a living human with end-stage renal disease'

Biography

Tatsuo Kawai

Dr Tatsuo Kawai, MD, PhD, is a Professor of Surgery at Harvard Medical School and holds the A. Benedict Cosimi Chair in Transplant Surgery at Massachusetts General Hospital (MGH). He also serves as the Director of the Legorreta Center for Clinical Transplantation Tolerance. Since joining MGH Transplant Surgery in 1997, he has developed a groundbreaking clinical protocol to induce immunological tolerance in HLA-mismatched kidney transplantation (New England Journal of Medicine in 2008). In the field of xenotransplantation, he has achieved over two years of survival for genetically edited kidney xenografts in nonhuman primates (Nature in 2023). Most recently, in March 2024, Dr Kawai successfully performed the world’s first kidney xenotransplantation using a pig with 69 genomic edits in a living patient with end-stage renal disease.

 

The Chief Medical Officer has confirmed that attendance at the Surgical Grand Rounds can count toward internal CPD, with 1 point awarded per hour. Please note that in-person attendance is required, and you will need to sign the attendance register.

 

Chair: Professor Fadi Issa

All members of the University and NHS clinical staff are welcome.

Please email Louise King if you would like to attend online.